NUENEUTRAL

Return on Equity (ROE)

12.3%

Updated 296h ago

Sector Performance

45th percentile

NUE

12.3%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholder equity; NUE’s current ROE of 12.3% means it earns $0.123 for every $1 of equity.

This sits below the sector median of 14.2%, placing NUE in the 44th percentile among peers. The year-over-year change is not available, but the quarter-over-quarter jump of +48.2% — from 8.3% to 12.3% — shows a sharp recent improvement. The combination of a below-median level with a strong upward trend suggests moderate risk (the company still lags the sector) but also near-term opportunity if the improvement continues. This metric neither reinforces nor contradicts the overall NEUTRAL verdict: the level is less favorable than peers, yet the rapid increase justifies holding a steady, unbiased view.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about NUE?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are NUE's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

Advertisement

Master NUE's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full NUE research report

Free account — no credit card

NUE

12.3%

Sector Median

13.8%

Sector Avg

31.4%

How NUE's Return on Equity (ROE) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.